Literature DB >> 24881053

Should we measure dyspnoea in everyone?

Robert B Banzett1, Carl R O'Donnell2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24881053      PMCID： PMC4096708          DOI： 10.1183/09031936.00031114

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  30 in total

1.  Respiratory symptoms as predictors of all-cause mortality in an urban community: a 30-year follow-up.

Authors:  A Frostad; V Søyseth; A Andersen; A Gulsvik
Journal:  J Intern Med       Date:  2006-05       Impact factor: 8.989

2.  The MRC breathlessness scale.

Authors:  Chris Stenton
Journal:  Occup Med (Lond)       Date:  2008-05       Impact factor: 1.611

3.  The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnea: a qualitative phase 1 study.

Authors:  Sara Booth; Morag Farquhar; Marjolein Gysels; Claudia Bausewein; Irene J Higginson
Journal:  Palliat Support Care       Date:  2006-09

4.  The experience of breathlessness in lung cancer.

Authors:  M O'Driscoll; J Corner; C Bailey
Journal:  Eur J Cancer Care (Engl)       Date:  1999-03       Impact factor: 2.520

5.  Prognostic significance of dyspnea in patients referred for cardiac stress testing.

Authors:  Aiden Abidov; Alan Rozanski; Rory Hachamovitch; Sean W Hayes; Fatma Aboul-Enein; Ishac Cohen; John D Friedman; Guido Germano; Daniel S Berman
Journal:  N Engl J Med       Date:  2005-11-03       Impact factor: 91.245

6.  Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Authors:  J C Bestall; E A Paul; R Garrod; R Garnham; P W Jones; J A Wedzicha
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

7.  The experience of dyspnea in late-stage cancer. Patients' and nurses' perspectives.

Authors:  D K Roberts; S E Thorne; C Pearson
Journal:  Cancer Nurs       Date:  1993-08       Impact factor: 2.592

Review 8.  Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases.

Authors:  C Bausewein; S Booth; M Gysels; I Higginson
Journal:  Cochrane Database Syst Rev       Date:  2008-04-16

Review 9.  Which measurement scales should we use to measure breathlessness in palliative care? A systematic review.

Authors:  Saskie Dorman; Anthony Byrne; Adrian Edwards
Journal:  Palliat Med       Date:  2007-03-15       Impact factor: 4.762

10.  SOME PRELIMINARY FINDINGS ON PHYSICAL COMPLAINTS FROM A PROSPECTIVE STUDY OF 1,064,004 MEN AND WOMEN.

Authors:  E C HAMMOND
Journal:  Am J Public Health Nations Health       Date:  1964-01
View more
  5 in total

Review 1.  Inspiring change: humanities and social science insights into the experience and management of breathlessness.

Authors:  Rebecca Oxley; Jane Macnaughton
Journal:  Curr Opin Support Palliat Care       Date:  2016-09       Impact factor: 2.302

2.  Prognostic Importance of Dyspnea for Cardiovascular Outcomes and Mortality in Persons without Prevalent Cardiopulmonary Disease: The Atherosclerosis Risk in Communities Study.

Authors:  Mario Santos; Dalane W Kitzman; Kunihiro Matsushita; Laura Loehr; Carla A Sueta; Amil M Shah
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

Review 3.  Improving the quality of life of people with advanced respiratory disease and severe breathlessness.

Authors:  Sara Booth; Miriam J Johnson
Journal:  Breathe (Sheff)       Date:  2019-09

4.  Validity and reliability of the Multidimensional Dyspnoea Profile in older adults.

Authors:  Eralda Hegendörfer; Alexander Doukhopelnikoff; Jean-Marie Degryse
Journal:  ERJ Open Res       Date:  2021-04-12

5.  Are within-person Numerical Rating Scale (NRS) ratings of breathlessness 'on average' valid in advanced disease for patients and for patients' informal carers?

Authors:  Joshua Wade; Silvia Mendonca; Sara Booth; Gail Ewing; A Carole Gardener; Morag Farquhar
Journal:  BMJ Open Respir Res       Date:  2017-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.